SecBot SecBot
Insider Cluster (3 insiders) ·Filed Apr 20, 2026

BCAX

Bicara Therapeutics Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed6mo ago
Insider cluster: 3 insiders, $0.7M total
Actionable Insight • Neutral

Insider sales are too small to signal negative conviction. The cluster appears to be routine portfolio diversification/tax planning. Focus on upcoming clinical catalysts (e.g., Phase 2 data) for near-term price action.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$21.28
T+0 close · Apr 28, 2026 · via day close
Latest settled
+26.97%
T+60 · $27.02
Vs SPY
+22.86%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Apr 29 $21.28entry
  2. T+1 · 7mo ago +1.41%α +0.39% · $21.58
  3. T+5 · 7mo ago +11.75%α +8.64% · $23.78
  4. T+20 · 6mo ago +2.21%α −3.84% · $21.75
  5. T+60 · 4mo ago +26.97%α +22.86% · $27.02

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Three top executives (CEO, CFO, CMO) sold a combined $692K in BCAX stock over the past week, but this represents only ~0.05% of the $1.5B market cap, making the cluster economically trivial and routine.

Key Financial Metrics

Direction
selling
Total Value
$692.0K
Insiders
3

Key Facts

  • CEO Claire Mazumdar sold 15K shares at ~$23.61 for $354K on Apr 20
  • CFO Ivan Hyep sold 9.2K shares at ~$23.00 for $212K on Apr 21
  • CMO David Raben sold 5.5K shares at ~$22.88 for $126K on Apr 27 (after exercising options)
  • Total open-market sales: ~$692K, or ~0.046% of BCAX's $1.5B market cap

Financial Impact

Insider selling totals ~$692K, negligible relative to market cap

insider holdingsfloat

Risk Factors

  • No material risk from this insider activity

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
80% bullish (20 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-BCAX-1777420424259

Track record

26 reports on BCAX

Performance horizon

1 of 3 bullish or bearish reports moved the stock their way by T+20. Best: +5.65% at T+20 after the Apr 15, 2026 report. 1 of 3 went positive at some point.

Filters
  1. Nov 9, 20267d ago Press Release Neutral 4/10 Entry $9.98 Now $9.75 −2.30% settles Dec 8
  2. Nov 4, 202612d ago Institutional Cluster Neutral 2/10 Entry $8.89 Now $9.75 +9.67% settles Dec 3
  3. Nov 4, 202612d ago Press Release Neutral 2/10 Entry $8.89 Now $9.75 +9.67% settles Dec 3
  4. Oct 7, 20265w ago SC 13G/A Neutral 3/10 Entry $16.42 to $8.89 Now $9.75 −40.62% ▼ −45.86% −44.52% vs SPY
  5. Oct 5, 20266w ago Press Release Neutral 2/10 Entry $17.29 to $9.13 Now $9.75 −43.61% ▼ −47.19% −44.73% vs SPY
  6. Sep 22, 20267w ago Institutional Cluster Bullish 4/10 Entry $22.78 to $18.35 Now $9.75 −57.20% ▼ −19.45% −18.89% vs SPY
  7. Aug 25, 202611w ago 8-K Neutral 2/10 Entry $24.73 to $19.78 Now $9.75 −60.57% ▼ −20.02% −20.24% vs SPY
  8. Aug 14, 202613w ago Press Release Neutral 2/10 Entry $24.28 to $23.20 Now $9.75 −59.84% ▼ −4.45% −2.46% vs SPY
  9. Aug 12, 202613w ago Insider Cluster Neutral Not scored Entry $23.63 to $22.81 Now $9.75 −58.74% ▼ −3.47% −1.72% vs SPY
  10. Aug 12, 202613w ago Insider Cluster Neutral 4/10 Entry $23.63 to $22.81 Now $9.75 −58.74% ▼ −3.47% −1.72% vs SPY
Showing 10 of 26

US Market Status

Market Closed · Opens Wed (10h 45m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 28, 2026